Home Applications 021606 Application 021606
Type NDA
Sponsor ABBVIE Application Products# Product, Drug, Ingredient table Product Drug Ingredient Form Strength Reference drug Reference standard 001 ZEMPLAR PARICALCITOL CAPSULE;ORAL 1MCG Yes No 002 ZEMPLAR PARICALCITOL CAPSULE;ORAL 2MCG Yes No 003 ZEMPLAR PARICALCITOL CAPSULE;ORAL 4MCG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons** Yes No
Source provenance: Browse the complete Orange Book source catalog · source snapshot 42 .
Orange Book products# Current product rows page 1 of 1 · 3 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date N021606-001 ZEMPLAR PARICALCITOL 1MCG CAPSULE / ORAL RLD 2005-05-26 N021606-002 ZEMPLAR PARICALCITOL 2MCG CAPSULE / ORAL RLD 2005-05-26 N021606-003 ZEMPLAR PARICALCITOL 4MCG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** CAPSULE / ORAL RLD 2005-05-26
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Product history page 1 of 4 · 126 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-08-18 06:07:40 2026-07 N021606-001 ZEMPLAR 1MCG CAPSULE / ORAL RLD 2005-05-26 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N021606-002 ZEMPLAR 2MCG CAPSULE / ORAL RLD 2005-05-26 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N021606-003 ZEMPLAR 4MCG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** CAPSULE / ORAL RLD 2005-05-26 caaa826d4ba7…2026-02-19 14:30 UTC 2026-02 N021606-001 ZEMPLAR 1MCG CAPSULE / ORAL RLD 2005-05-26 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N021606-002 ZEMPLAR 2MCG CAPSULE / ORAL AB RLD 2005-05-26 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N021606-003 ZEMPLAR 4MCG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** CAPSULE / ORAL RLD 2005-05-26 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N021606-001 ZEMPLAR 1MCG CAPSULE / ORAL RLD 2005-05-26 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N021606-002 ZEMPLAR 2MCG CAPSULE / ORAL AB RLD 2005-05-26 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N021606-003 ZEMPLAR 4MCG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** CAPSULE / ORAL RLD 2005-05-26 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 N021606-001 ZEMPLAR 1MCG CAPSULE / ORAL AB RLD 2005-05-26 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N021606-002 ZEMPLAR 2MCG CAPSULE / ORAL AB RLD 2005-05-26 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N021606-003 ZEMPLAR 4MCG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** CAPSULE / ORAL RLD 2005-05-26 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N021606-001 ZEMPLAR 1MCG CAPSULE / ORAL AB RLD 2005-05-26 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N021606-002 ZEMPLAR 2MCG CAPSULE / ORAL AB RLD 2005-05-26 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N021606-003 ZEMPLAR 4MCG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** CAPSULE / ORAL RLD 2005-05-26 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N021606-001 ZEMPLAR 1MCG CAPSULE / ORAL AB RLD 2005-05-26 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N021606-002 ZEMPLAR 2MCG CAPSULE / ORAL AB RLD 2005-05-26 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N021606-003 ZEMPLAR 4MCG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** CAPSULE / ORAL RLD 2005-05-26 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N021606-001 ZEMPLAR 1MCG CAPSULE / ORAL AB RLD 2005-05-26 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N021606-002 ZEMPLAR 2MCG CAPSULE / ORAL AB RLD 2005-05-26 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N021606-003 ZEMPLAR 4MCG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** CAPSULE / ORAL RLD 2005-05-26 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N021606-001 ZEMPLAR 1MCG CAPSULE / ORAL AB RLD 2005-05-26 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N021606-002 ZEMPLAR 2MCG CAPSULE / ORAL AB RLD 2005-05-26 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N021606-003 ZEMPLAR 4MCG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** CAPSULE / ORAL RLD 2005-05-26 2680178bc6a6…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N021606-001 ZEMPLAR 1MCG CAPSULE / ORAL AB RLD 2005-05-26 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N021606-002 ZEMPLAR 2MCG CAPSULE / ORAL AB RLD 2005-05-26 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N021606-003 ZEMPLAR 4MCG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** CAPSULE / ORAL RLD 2005-05-26 5bbf6a4d5a75…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N021606-001 ZEMPLAR 1MCG CAPSULE / ORAL AB RLD 2005-05-26 d8e5a09893c0…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N021606-002 ZEMPLAR 2MCG CAPSULE / ORAL AB RLD 2005-05-26 d8e5a09893c0…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N021606-003 ZEMPLAR 4MCG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** CAPSULE / ORAL RLD 2005-05-26 d8e5a09893c0…2024-10-29 15:01 UTC 2024-10 N021606-001 ZEMPLAR 1MCG CAPSULE / ORAL AB RLD 2005-05-26 d06236e962d9…2024-10-29 15:01 UTC 2024-10 N021606-002 ZEMPLAR 2MCG CAPSULE / ORAL AB RLD 2005-05-26 d06236e962d9…2024-10-29 15:01 UTC 2024-10 N021606-003 ZEMPLAR 4MCG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** CAPSULE / ORAL RLD 2005-05-26 d06236e962d9…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 N021606-001 ZEMPLAR 1MCG CAPSULE / ORAL AB RLD 2005-05-26 79d66fd596c7…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 N021606-002 ZEMPLAR 2MCG CAPSULE / ORAL AB RLD 2005-05-26 79d66fd596c7…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 N021606-003 ZEMPLAR 4MCG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** CAPSULE / ORAL RLD 2005-05-26 79d66fd596c7…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 N021606-001 ZEMPLAR 1MCG CAPSULE / ORAL AB RLD 2005-05-26 301d65b070ca…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 N021606-002 ZEMPLAR 2MCG CAPSULE / ORAL AB RLD 2005-05-26 301d65b070ca…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 N021606-003 ZEMPLAR 4MCG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** CAPSULE / ORAL RLD 2005-05-26 301d65b070ca…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 N021606-001 ZEMPLAR 1MCG CAPSULE / ORAL AB RLD 2005-05-26 1e350fbaab3a…
Observed Orange Book normalized TE history# Normalized TE history page 1 of 2 · 78 observed states.
Observed Orange Book exclusivity history# Exclusivity history page 1 of 3 · 96 observed states.
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 1 matching rows.
NDC Listings For This Application# NDC listings for this application page 1 of 1 · 31 matching rows.
NDC, Name, Nonproprietary name table NDC Name Nonproprietary name Labeler Marketing category Status 0074-4314 Zemplar Paricalcitol AbbVie Inc. NDA Current 0074-4314 Zemplar Paricalcitol AbbVie Inc. NDA Current 0074-4314 Zemplar Paricalcitol AbbVie Inc. NDA Current 0074-9036 Zemplar Paricalcitol AbbVie Inc. NDA Current 0074-9036 Zemplar Paricalcitol AbbVie Inc. NDA Current 0074-9036 Zemplar Paricalcitol AbbVie Inc. NDA Current 0074-9036 Zemplar Paricalcitol AbbVie Inc. NDA Current 0074-9036 Zemplar Paricalcitol AbbVie Inc. NDA Current 0074-9036 Zemplar Paricalcitol AbbVie Inc. NDA Current 0074-9036 Zemplar Paricalcitol AbbVie Inc. NDA Current 0074-9037 Zemplar Paricalcitol AbbVie Inc. NDA Current 0074-9037 Zemplar Paricalcitol AbbVie Inc. NDA Current 0074-9037 Zemplar Paricalcitol AbbVie Inc. NDA Current 0074-9037 Zemplar Paricalcitol AbbVie Inc. NDA Current 0074-9037 Zemplar Paricalcitol AbbVie Inc. NDA Current 0074-9037 Zemplar Paricalcitol AbbVie Inc. NDA Current 0074-9037 Zemplar Paricalcitol AbbVie Inc. NDA Current 68382-266 Paricalcitol Paricalcitol Zydus Pharmaceuticals USA Inc NDA AUTHORIZED GENERIC Current 68382-266 Paricalcitol Paricalcitol Zydus Pharmaceuticals USA Inc NDA AUTHORIZED GENERIC Current 68382-267 Paricalcitol Paricalcitol Zydus Pharmaceuticals USA Inc NDA AUTHORIZED GENERIC Current 68382-267 Paricalcitol Paricalcitol Zydus Pharmaceuticals USA Inc NDA AUTHORIZED GENERIC Current 68382-330 Paricalcitol Paricalcitol Zydus Pharmaceuticals USA Inc NDA AUTHORIZED GENERIC Current 68382-330 Paricalcitol Paricalcitol Zydus Pharmaceuticals USA Inc NDA AUTHORIZED GENERIC Current 68382-330 Paricalcitol Paricalcitol Zydus Pharmaceuticals USA Inc NDA AUTHORIZED GENERIC Current 68382-330 Paricalcitol Paricalcitol Zydus Pharmaceuticals USA Inc NDA AUTHORIZED GENERIC Current 68382-330 Paricalcitol Paricalcitol Zydus Pharmaceuticals USA Inc NDA AUTHORIZED GENERIC Current 68382-331 Paricalcitol Paricalcitol Zydus Pharmaceuticals USA Inc NDA AUTHORIZED GENERIC Current 68382-331 Paricalcitol Paricalcitol Zydus Pharmaceuticals USA Inc NDA AUTHORIZED GENERIC Current 68382-331 Paricalcitol Paricalcitol Zydus Pharmaceuticals USA Inc NDA AUTHORIZED GENERIC Current 68382-331 Paricalcitol Paricalcitol Zydus Pharmaceuticals USA Inc NDA AUTHORIZED GENERIC Current 68382-331 Paricalcitol Paricalcitol Zydus Pharmaceuticals USA Inc NDA AUTHORIZED GENERIC Current